Micall2 Is Responsible for the Malignancy of Clear Cell Renal Cell Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Micall2 Is Responsible for the Malignancy of Clear Cell Renal Cell Carcinoma

Published:2023 Issue:1 Volume:66 Page:171-179
ISSN:1346-8049
Container-title:Yonago Acta Medica
language:en
Short-container-title:Yonago Acta Med.

Author:

Zeng Xianyou¹,Wang Hongquan²,Yang Jia²,Hu Jing³

Affiliation:

1. Department of Urology, The Affiliated Hospital of Jinggangshan University, Jian, Jiangxi, China

2. Department of Urology, Chongqing Fengdu people’s Hospital, Chongqing, China

3. Department of Stomatology, The Affiliated Hospital of Jinggangshan University, Jian, Jiangxi, China

Publisher

Tottori University Faculty of Medicine

Subject

General Medicine

Link

https://www.jstage.jst.go.jp/article/yam/66/1/66_2023.02.021/_pdf

Reference17 articles.

1. 1. Yu G, Li H, Wang J, Gumireddy K, Li A, Yao W, et al. miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells. J Urol. 2014;192:1229-37. PMID:24866595, DOI:10.1016/j.juro.2014.05.094

2. 2. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs-part A: renal, penile, and testicular tumours. Eur Urol. 2016;70:93-105. PMID:26935559, DOI:10.1016/j.eururo.2016.02.029

3. 3. Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, et al. Renal cell carcinoma. Nat Rev Dis Primers. 2017;3:17009. PMID:28276433, DOI:10.1038/nrdp.2017.9

4. 4. Clark DJ, Dhanasekaran SM, Petralia F, Pan J, Song X, Hu Y, et al.; Clinical Proteomic Tumor Analysis Consortium. Integrated Proteogenomic Characterization of Clear Cell Renal Cell Carcinoma. Cell. 2020;180:207. PMID:31923397, DOI:10.1016/j.cell.2019.12.026

5. 5. Li QK, Pavlovich CP, Zhang H, Kinsinger CR, Chan DW. Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers. Semin Cancer Biol. 2019;55:8-15. PMID:30055950, DOI:10.1016/j.semcancer.2018.06.004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High MICAL-L2 promotes cancer progression and drug resistance of renal clear cell carcinoma cell via stabilization of ACTN4 and following vimentin expression;2024-06-25

2. Recent Advances in the Management of Clear Cell Renal Cell Carcinoma: Novel Biomarkers and Targeted Therapies;Cancers;2023-06-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3